Neuroanatomical changes in early Parkinson's disease with mild cognitive impairment: a VBM study; the Parkinson's Disease Cognitive Impairment Study (PaCoS).


Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 20 03 2020
accepted: 30 12 2020
pubmed: 16 1 2021
medline: 7 9 2021
entrez: 15 1 2021
Statut: ppublish

Résumé

Mild cognitive impairment (MCI) is common in Parkinson's disease (PD), but the underlying pathological mechanism has not been fully understood. Voxel-based morphometry could be used to evaluate regional atrophy and its relationship with cognitive performances in early PD-MCI. One hundred and six patients with PD were recruited from a larger cohort of patients, the Parkinson's Disease Cognitive Impairment Study (PaCoS). Subject underwent a T1-3D MRI and a complete clinical and neuropsychological evaluation. Patients were divided into PD with normal cognition (PD-NC) and PD-MCI according to the MDS level II criteria-modified for PD-MCI. A subgroup of early patients with short disease duration (≤ 2 years) was also identified. VBM analysis between PD-NC and PD-MCI and between early PD-NC and PD-MCI was performed using two-sample t tests with whole-brain statistical threshold of p < 0.001 uncorrected in the entire PD group and p < 0.05 FWE inside ROIs, in the early PD. Forty patients were diagnosed with MCI and 66 were PD-NC. PD-MCI patients showed significant gray matter (GM) reduction in several brain regions, including frontal gyrus, precuneus, angular gyrus, temporal lobe, and cerebellum. Early PD-MCI showed reduction in GM density in superior frontal gyrus and cerebellum. Moreover, correlation analysis between neuropsychological performances and GM volume of early PD-MCI patients showed associations between performances of Raven and superior frontal gyrus volume, Stroop time and inferior frontal gyrus volume, accuracy of Barrage and volume of precuneus. The detection of frontal and cerebellar atrophy, even at an early stage, could be used as an early marker of PD-related cognitive impairment.

Identifiants

pubmed: 33447925
doi: 10.1007/s10072-020-05034-9
pii: 10.1007/s10072-020-05034-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3723-3731

Informations de copyright

© 2021. Fondazione Società Italiana di Neurologia.

Références

Kalia LV, Lang AE (2016) Parkinson disease in 2015: evolving basic, pathological and clinical concepts in PD. Nat Rev Neurol 12(2):65–66
doi: 10.1038/nrneurol.2015.249
Aarsland D, Kurz MW (2010) The epidemiology of dementia associated with Parkinson disease. J Neurol Sci 289(1–2):18–22
doi: 10.1016/j.jns.2009.08.034
Baschi R, Nicoletti A, Restivo V, Recca D, Zappia M, Monastero R (2018) Frequency and correlates of subjective memory complaints in Parkinson’s disease with and without mild cognitive impairment: data from the Parkinson’s disease cognitive impairment study. J Alzheimer’s dis. J Alzheimers Dis 63(3):1015–1024
Litvan I, Aarsland D, Adler CH et al (2011) MDS task force on mild cognitive impairment in Parkinson’s disease: critical review of PD-MCI. Mov Disord 15(10):1814–1824
doi: 10.1002/mds.23823
Pedersen KF, Larsen JP, Tysnes OB, Alves G (2013) Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study. JAMA Neurol 70(5):580–586
doi: 10.1001/jamaneurol.2013.2110
Yarnall AJ, Breen DP, Duncan GW, ICICLE-PD Study Group (2014) Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study. Neurology 82(4):308–316
doi: 10.1212/WNL.0000000000000066
Domellöf ME, Ekman U, Forsgren L, Elgh E (2015) Cognitive function in the early phase of Parkinson’s disease, a five-year follow-up. Acta Neurol Scand 132(2):79–88
doi: 10.1111/ane.12375
Emre M (2003) What causes mental dysfunction in Parkinson’s disease? Mov Disord 8(Suppl 6):S63–S71
doi: 10.1002/mds.10565
Mak E, Zhou J, Tan LC et al (2014) Cognitive deficits in mild Parkinson’s disease are associated with distinct areas of grey matter atrophy. J Neurol Neurosurg Psychiatry 85(5):576–580
doi: 10.1136/jnnp-2013-305805
Segura B, Baggio HC, Marti MJ, Valldeoriola F, Compta Y, Garcia-Diaz AI, Vendrell P, Bargallo N, Tolosa E, Junque C (2014) Cortical thinning associated with mild cognitive impairment in Parkinson’s disease. Mov Disord 29(12):1495–1503
doi: 10.1002/mds.25982
Zhang J, Zhang YT, Hu WD, Li L, Liu GY, Bai YP (2015) Gray matter atrophy in patients with Parkinson’s disease and those with mild cognitive impairment: a voxel-based morphometry study. Int J Clin Exp Med 8(9):15383–15392
pubmed: 26629027 pmcid: 4658916
Lee JE, Cho KH, Song SK, Kim HJ, Lee HS, Sohn YH, Lee PH (2014) Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson’s disease. J Neurol Neurosurg Psychiatry 85(1):7–16
doi: 10.1136/jnnp-2013-305062
Chen B, Wang S, Sun W, Shang X, Liu H, Liu G, Gao J, Fan G (2017) Functional and structural changes in gray matter of Parkinson’s disease patients with mild cognitive impairment. Eur J Radiol 93:16–23
doi: 10.1016/j.ejrad.2017.05.018
Xu Y, Yang J, Hu X, Shang H (2016) Voxel-based meta-analysis of gray matter volume reductions associated with cognitive impairment in Parkinson’s disease. J Neurol 263(6):1178–1187
doi: 10.1007/s00415-016-8122-3
Danti S, Toschi N, Diciotti S, Tessa C, Poletti M, del Dotto P, Lucetti C (2015) Cortical thickness in de novo patients with Parkinson disease and mild cognitive impairment with consideration of clinical phenotype and motor laterality. Eur J Neurol 22(12):1564–1572
doi: 10.1111/ene.12785
Pereira JB, Svenningson P, Weintraub D et al (2014) Initial cognitive decline is associated with cortical thinning in early Parkinson disease. Neurology 82(22):2017–2025
doi: 10.1212/WNL.0000000000000483
Uribe C, Segura B, Baggio HC, Abos A, Garcia-Diaz AI, Campabadal A, Marti MJ, Valldeoriola F, Compta Y, Tolosa E, Junque C (2018) Cortical atrophy patterns in early Parkinson’s disease patients using hierarchical cluster analysis. Parkinsonism Relat Disord 50:3–9
doi: 10.1016/j.parkreldis.2018.02.006
Jia X, Wang Z, Yang T, Li Y, Gao S, Wu G, Jiang T, Liang P (2019) Entorhinal cortex atrophy in early, drug-naive Parkinson’s disease with mild cognitive impairment. Aging Dis 10(6):1221–1232
doi: 10.14336/AD.2018.1116
Klein JC, Rolinski M, Griffanti L, Szewczyk-Krolikowski K, Baig F, Ruffmann C, Groves AR, Menke RAL, Hu MT, Mackay C (2018) Cortical structural involvement and cognitive dysfunction in early Parkinson’s disease. NMR Biomed 31(4):e3900
doi: 10.1002/nbm.3900
Monastero R, Cicero CE, Baschi R, Davì M, Luca A, Restivo V, Zangara C, Fierro B, Zappia M, Nicoletti A (2018) Mild cognitive impairment in Parkinson’s disease: the Parkinson’s Disease Cognitive Study (PACOS). J Neurol 265(5):1050–1058
doi: 10.1007/s00415-018-8800-4
Gibb WR, Lees AJ (1989) The significance of the Lewy body in the diagnosis of idiopathic Parkinson’s disease. Neuropathol Appl Neurobiol 15:27–44
doi: 10.1111/j.1365-2990.1989.tb01147.x
Fahn, S., Elton, R. and Members of the UPDRS Development Committee. The Unified Parkinson’s Disease Rating Scale. In: Fahn, S., Marsden, C.D., Calne, D.B. and Goldstein, M., Eds., 1987 Recent Developments in Parkinson’s Disease, Vol. 2, McMellam Health Care Information, Florham Park, 153–163
Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17(5):427–442
doi: 10.1212/WNL.17.5.427
Tomlinson CL, Stowe R, Patel S et al (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 2010 25(15):2649–2653
Litvan I, Goldman JC, Tröster AI et al (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force Guidelines. Mov Disord 27(3):349–356
doi: 10.1002/mds.24893
Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjögren M, Wallin A, Ader H, Leys D, Pantoni L, Pasquier F, Erkinjuntti T, Scheltens P, European Task Force on Age-Related White Matter Changes (2001) A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32(6):1318–1322
doi: 10.1161/01.STR.32.6.1318
Song SK, Lee JE, Park HJ, Sohn YH, Lee JD, Lee PH (2011) The pattern of cortical atrophy in patients with Parkinson’s disease according to cognitive status. Mov Disord 26(2):289–296
doi: 10.1002/mds.23477
Melzer TR, Watts R, MacAskill MR et al (2012) Grey matter atrophy in cognitively impaired Parkinson’s disease. J Neurol Neurosurg Psychiatry 83(2):188–194
doi: 10.1136/jnnp-2011-300828
Pagonabarraga J, Corcuera-Solano I, Vives-Gilabert Y, Llebaria G, García-Sánchez C, Pascual-Sedano B, Delfino M, Kulisevsky J, Gómez-Ansón B (2013) Pattern of regional cortical thinning associated with cognitive deterioration in Parkinson’s disease. PLoS One 8(1):e54980
doi: 10.1371/journal.pone.0054980
Noh SW, Han YH, Mun CW, Chung EJ, Kim EG, Ji KH, Seo JH, Kim SJ (2014) Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson’s disease with mild cognitive impairment. J Neurol Sci 347(1–2):210–213
doi: 10.1016/j.jns.2014.09.049
Biundo R, Calabrese M, Weis L, Facchini S, Ricchieri G, Gallo P, Antonini A (2013) Anatomical correlates of cognitive functions in early Parkinson’s disease patients. PLoS One 8(5):e64222
doi: 10.1371/journal.pone.0064222
Amboni M, Tessitore A, Esposito F, Santangelo G, Picillo M, Vitale C, Giordano A, Erro R, de Micco R, Corbo D, Tedeschi G, Barone P (2015) Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease. J Neurol 262(2):425–434
doi: 10.1007/s00415-014-7591-5
Baggio HC, Segura B, Sala-Llonch R, Marti MJ, Valldeoriola F, Compta Y, Tolosa E, Junqué C (2015) Cognitive impairment and resting-state network connectivity in Parkinson’s disease. Hum Brain Mapp 36(1):199–212
doi: 10.1002/hbm.22622
Anderkova L, Barton M, Rektorova I (2017) Striato-cortical connections in Parkinson’s and Alzheimer’s disease: relation to cognition. Mov Disord 32(6):917–922
doi: 10.1002/mds.26956
Nee DE, Brown JW, Askren MK, Berman MG, Demiralp E, Krawitz A, Jonides J (2013) A meta-analysis of executive components of working memory. Cereb Cortex 23(2):264–282
doi: 10.1093/cercor/bhs007
Stoodley CJ, Schmahmann JD (2009) Functional topography in the human cerebellum: a meta-analysis of neuroimaging studies. Neuroimage 44(2):489–501
doi: 10.1016/j.neuroimage.2008.08.039
Jha M, Jhunjhunwala K, Sankara B et al (2015) Neuropsychological and imaging profile of patients with Parkinson’s disease and freezing of gait. Parkinsonism Relat Disord 21(10):1184–1190
doi: 10.1016/j.parkreldis.2015.08.009
Gao L, Zhang J, Hou Y et al (2017) The cerebellum in dual-task performance in Parkinson’s disease. Sci rep 30:7–45662
Carlesimo GA, Caltagirone C, Gainotti G (1996) The mental deterioration battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The group for the standardization of the mental deterioration battery. Eur Neurol 36(6):378–384
doi: 10.1159/000117297
Pereira JB, Aarsland D, Ginestet CE, Lebedev AV, Wahlund LO, Simmons A, Volpe G, Westman E (2015) Aberrant cerebral network topology and mild cognitive impairment in early Parkinson’s disease. Hum Brain Mapp 36(8):2980–2995
doi: 10.1002/hbm.22822
Uttl B, Graf P (1997) Color-Word Stroop test performance across the adult life span. J Clin Exp Neuropsychol 19(3):405–420
doi: 10.1080/01688639708403869
Aron AR, Fletcher PC, Bullmore ET et al (2003). Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat Neurosci 6(2):115-116. Erratum in: Nat Neurosci 6(12):1329
Zhang S, Li CS (2012) Functional connectivity mapping of the human precuneus by resting state fMRI. Neuroimage 59(4):3548–3562
doi: 10.1016/j.neuroimage.2011.11.023

Auteurs

Giulia Donzuso (G)

Department of Surgical and Medical Sciences Advanced Technologies "G.F. Ingrassia", University of Catania, Via Santa Sofia 78, Catania, 95123, Italy.

Roberto Monastero (R)

Department of Experimental Biomedicine and Clinical Neuroscience (BioNeC), University of Palermo, Palermo, Italy.

Calogero E Cicero (CE)

Department of Surgical and Medical Sciences Advanced Technologies "G.F. Ingrassia", University of Catania, Via Santa Sofia 78, Catania, 95123, Italy.

Antonina Luca (A)

Department of Surgical and Medical Sciences Advanced Technologies "G.F. Ingrassia", University of Catania, Via Santa Sofia 78, Catania, 95123, Italy.

Giovanni Mostile (G)

Department of Surgical and Medical Sciences Advanced Technologies "G.F. Ingrassia", University of Catania, Via Santa Sofia 78, Catania, 95123, Italy.

Loretta Giuliano (L)

Department of Surgical and Medical Sciences Advanced Technologies "G.F. Ingrassia", University of Catania, Via Santa Sofia 78, Catania, 95123, Italy.

Roberta Baschi (R)

Department of Experimental Biomedicine and Clinical Neuroscience (BioNeC), University of Palermo, Palermo, Italy.

Maria Caccamo (M)

Department of Experimental Biomedicine and Clinical Neuroscience (BioNeC), University of Palermo, Palermo, Italy.

Cesare Gagliardo (C)

Department of Biopathology and Medical Biotechnologies, Section of Radiological Sciences, University of Palermo, Palermo, Italy.

Stefano Palmucci (S)

Radiodiagnostic and Radiotherapy Unit, University Hospital "Policlinico-Vittorio Emanuele", Catania, Italy.

Mario Zappia (M)

Department of Surgical and Medical Sciences Advanced Technologies "G.F. Ingrassia", University of Catania, Via Santa Sofia 78, Catania, 95123, Italy.

Alessandra Nicoletti (A)

Department of Surgical and Medical Sciences Advanced Technologies "G.F. Ingrassia", University of Catania, Via Santa Sofia 78, Catania, 95123, Italy. anicolet@unict.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH